Trial Profile
A Study to Evaluate the Efficacy and Safety of Lacosamide in Patients With Status Epilepticus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Status epilepticus
- Focus Adverse reactions; Therapeutic Use
- 02 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology